Drug Database
Back to search

Belgium· BE-AMP-SAM444911-00

Cholib 145 mg - 40 mg

A simvastatin and fenofibrate product containing fenofibrate, registered in Belgium by Viatris Healthcare. The same ATC class is registered in 10 of our 19 countries.

ATC C10BA04

Checked against FAMHP / AFMPS (Belgium) on

Informational only — not a medical device.

SOURCE REGISTER · BEFAMHP / AFMPS (Belgium)normalisedCholib 145 mg - 40 mgATCC10BA04REGISTER NO.BE-AMP-SAM444911-00PACKS LISTED0CHECKEDSeptember 26, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about fenofibrateAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Simvastatin and fenofibrate is registered in 10 of 19 countries.

Countries holding a registration under ATC C10BA04 (simvastatin and fenofibrate), each read from that country’s own register.

  • This record: Belgium, from FAMHP / AFMPS (Belgium)
  • 6 of them publish a price we can compare per daily dose
Search simvastatin and fenofibrate products by name

Simvastatin and fenofibrate · ATC C10BA04

10 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Polandprice
  • Switzerlandprice
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

FAMHP / AFMPS (Belgium)
Active substance
Fenofibrate
Manufacturer
Viatris Healthcare
Country
Belgium (BE)
ATC code
C10BA04
ATC class
Simvastatin and fenofibrate
Reimbursed
Not published by this register
Source register
FAMHP / AFMPS (Belgium)
Last checked
September 26, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

2 interactions on record for simvastatin and fenofibrate.

Mechanism, severity and management for each pair, from a commercially licensed source — included with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check simvastatin and fenofibrate against other medicinesHow interaction checks work

Simvastatin and fenofibrate · interactions on record

2 records

2 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
Mechanism and what to do, in the interaction check
Interaction register. Grades as the source publishes them.

Same medicine, other countries

Simvastatin and fenofibrate in 15 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All simvastatin and fenofibrate products

Authorised across Europe · EMA

The same active substance is authorised in 27 EEA countries. Names it is sold under:

  • Austria · Fenolip Retard, Lipcor
  • Bulgaria · Липантил, Липантил Супра
  • Cyprus · Lipidil Nt
  • Czechia · Fenofix, Fortilip
  • Germany · Cil, Elipsia
  • Estonia · Lipanthyl
  • Spain · Fenofibrate Teva, Fenofibrato Aurovitas
  • Finland · Lipanthyl Penta
  • France · Fegenor, Fenofibrate Almus
  • United Kingdom (Northern Ireland) · Fenofibrate, Fenofibrate Accord Uk
  • Greece · Fenobrat, Lipidil Nt
  • Croatia · Fenolip, Tricor
  • Hungary · Fenobrat, Fenoswiss
  • Ireland · Lipantil Micro, Lipantil Supra
  • Italy · Fenofibrato Aurobindo, Fenofibrato Eg
  • Lithuania · Lipanthyl
  • Luxembourg · Fenofibraat Eg, Fenogal Lidose
  • Latvia · Lipanthyl
  • Malta · Lipantil Supra
  • Netherlands · Fenogal
  • Norway · Thylip
  • Poland · Biofibrat, Fenardin
  • Portugal · Catalip, Catalip Micronizado
  • Romania · Fenofibrat Terapia, Lipanthyl Supra
  • Sweden · Lipanthyl, Thylip
  • Slovenia · Katalip
  • Slovakia · Fenofibrate Teva, Fenofix

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/a04bfe4a-39f9-49be-846d-40233f54290f
GET /v1/drugs/a04bfe4a-39f9-49be-846d-40233f54290f?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Film-coated tablet",
  "source": "afmps",
  "status": "AUTHORIZED",
  "name_en": "Cholib 145 mg - 40 mg",
  "name_fr": "Cholib 145 mg - 40 mg",
  "name_nl": "Cholib 145 mg - 40 mg",
  "amp_code": "SAM444911-00",
  "strengths": [
    "145.0000",
    "145.0000",
    "145.0000",
    "40.0000",
    "40.0000",
    "40.0000"
  ],
  "pack_count": 3,
  "substances": [
    "Fenofibrate",
    "Simvastatin",
    "Butylhydroxyanisole",
    "Docusate Sodium",
    "Lactose Monohydrate",
    "Sodium Laurilsulfate",
    "Sucrose"
  ],
  "medicine_type": "ALLOPATHIC",
  "atc_description": "Simvastatin and Fenofibrate",
  "authorisation_numbers": [
    "EU/1/13/866/004",
    "EU/1/13/866/003",
    "EU/1/13/866/006"
  ]
}
API referenceMCP serverPlans

See everything about simvastatin and fenofibrate.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console